Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug Advances

MICHAEL KREY
·2 min read
Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug Advances
Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug Advances

Regeneron Pharmaceuticals late Wednesday posted positive clinical trials data on its Covid-19 treatment and Thursday said a lung cancer drug received FDA priority review. Regeneron stock rose.